Improving the Prognosis for Cerebral Hemorrhage A Study of Clinical, Biological, and Imaging Markers
NCT07444853
Brain Diseases, Cardiovascular Diseases
Angers, France
View Trial DetailsNCT Number: NCT07100132
The objective of this observational study is to investigate the predictive value of various imaging signs in patients with intracerebral hemorrhage, thereby providing a reference for clinical diagnosis and treatment. The primary aim is to evaluate the association between specific imaging signs and both hematoma expansion and poor outcomes in these patients.
Trial opening soon.
Get NotifiedAll sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(1) Patients who were confirmed to have cerebral hemorrhage through head CT imaging examination upon admission; (2) Those who completed head CT and CTA within 8 hours of onset and had a follow-up CT within 24 hours of admission; (3) With complete clinical data.
Exclusion criteria
(1) Patients who cannot complete CT and CTA within the prescribed time; (2) Patients with secondary cerebral hemorrhage due to cerebral vascular malformations, brain tumors, brain trauma, cerebral aneurysms, etc.; (3) Patients who have been taking oral anticoagulants for a long time or have blood system diseases; (4) Primary intraventricular hemorrhage.
Time frame: From the end of the six-month period after discharge.
Contact information is provided by the study sponsor or research team.
The Affiliated Hospital Of Guizhou Medical University
Other
Research on the Clinical Value of Cranial CT and CTA in Patients With Cerebral Hemorrhage
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07444853
Brain Diseases, Cardiovascular Diseases
Angers, France
View Trial DetailsNCT07132996
Acute Brain Injury, Brain Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT04805177
Brain Diseases, Cardiovascular Diseases
Basel, Switzerland
View Trial DetailsNCT03338998
Brain Diseases, Cardiovascular Diseases
Palo Alto, California, United States
View Trial Details